Acer Truncatum Seed extract nervonic acid

Nervonic acid powder is a monounsaturated omega-9 fatty acid. Nervonic acid powder has been identified as important in the biosynthesis of nerve cell myelin. It is found in the sphingolipids of white matter in human body.Nervonic acid is used in the treatment of disorders involving demyelination, such as adrenoleukodystrophy and multiple sclerosis where there is a decreased level of nervonic acid in sphingolipids.

 Product Name: Nervonic Acid

Active Ingredient:Nervonic Acid 


Test Method:GC

Appearance: White Crystilline Powder

Particle Size:98% pass 80mesh

For more product information pls contact email

Applied in pharmacutical field:
Alzheimer : Nervonic Acid can be used in the treatment and adjuvant therapy of various nervous system diseases like alzheimer,Metabolic Endocrine diseases;

Brain health product:
Nervonic acid as a brain health food additive,nerve acid can be used in infants and young children to promote the development of brain, enhance memory and improve the level of intelligence development;
Applied in Health Care Product field:
Nutraceutical:Nervonic Acid used to treat skin diseases and improve vision; To enhance the protection of the skin stratum corneum, improve skin moisture content and defense capabilities;  Nutritional care for the optic nerve and retina;

Function of Nervonic acid

 1. Nervonic Acid can advance the re-growth of neuron. It possesses the following three medical effects:
2. Repair and dredge the speedway of transferring nervonic information nerve fiber to dredge the brain route.
3.Repair the injured cranial nerve cells.
4.Advance the re-growth of cranial nerve.
5.Nervonic acid can increase the energy of brain cells, advance the multiplication and differentiation of cells, prevent the cranial nerve cells from consenescence and injury, recover the clear perceive ability, distinguishing ability, study ability and memory of brain. It is effective to prevent senile dementia.


  1. 1.Craig, B. M., Can. J. Technol.34, 335–339 (1956)
  2. 2.Mikolajczak, K. L., T. K. Miwa, F. R. Earle, L. A. Wolff and Q. Jones, JAOCS38, 678–681 (1961)
  3. 3.Hilditch, T. P., and P. N. Williams, “The Chemical Constitution of Natural Fats”, 4th Ed., Chapman & Hall, London, 1964, pp. 294, 610.
  4. 4.Tremazi, S. A., N. V. Lovegren and R. O. Feuge, JAOCS42, 78–81 (1965).
  5. 5.Thomasson, H. J., and J. Boldingh, J. Nutr.56, 469–475 (1955).
  6. 6.Carroll, K. K., Can. J. Biochem. Physiol.40, 1229–1238 (1962).
  7. 7.O’Brien, J. S. and G. Rouser, J. Lipid Res.5, 339–342 (1964).
  8. 8.Carroll, K. K., J. Lipid Res.3, 388–390 (1962).
  9. 9.Folch, J., M. Lees and G. H. Sloane Stanley, J. Biol. Chem.226, 497–509 (1957).
  10. 10.Carroll, K. K., JAOCS40, 413–419 (1963).
  11. 11.Carroll, K. K., J. Lipid Res.2, 135–141 (1961).
  12. 12.Fieser, L. F., “Experiments in Organic Chemistry,” 3rd Ed., D. C. Heath & Co., Boston, Mass., 1955, p. 328.
  13. 13.Groom, V., and M. Sribney, J. Lipid Res.6, 220–221 (1965).
  14. 14.Dittmer, J. C., and D. J. Hanahan J. Biol. Chem.234, 1976–1982 (1959).
  15. 15.Dawson, R. M. C., Biochem. J.75, 45–53 (1960).
  16. 16.Gatt, S., Biochim. Biophys. Acta70, 370–380 (1963).
  17. 17.Göransson, G., Acta Physiol. Scand.63, 385–390 (1965).
  18. 18.Carroll, K. K., Can. J. Biochem. Physiol.37, 803–810 (1959).
  19. 19.Carroll, K. K., and R. L. Noble, Can. J. Biochem. Physiol.34, 981–991 (1956
  20. 20.Carroll, K. K., Can. J. Biochem. Physiol.40, 1115–1122 (1962).
  21. 21.Göransson, G. and T. Olivecrona, Acta Physiol. Scand.63, 121–127 (1965).
  22. 22.Dittmer, J. C., and D. J. Hanahan, J. Biol. Chem.234, 1983–1989 (1959).
  23. 23.Shafrir, E., S. Gatt and S. Khasis, Biochim. Biophys. Acta98, 365–371 (1965).
  24. 24.Göransson, G., Acta Physiol. Scand.64, 269–274 (1965).


电子邮件地址不会被公开。 必填项已用*标注